Life Science Angels
Life Science Angels offers angel capital to early-stage biotech and medical device companies as a California-based company.
Business Model:
Revenue: $5M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Life Science Angels Information
Geographic Data
Address: Life Science Angels Inc 1230 Bordeaux Drive
City: Sunnyvale
State: CA
Zip: 94089
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
5,367,364Website Global Rank
1,719Website Monthly Traffic
Twitter Followers
Description
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Contact Phone:
+14085411152
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2019 | TransformativeMed | Venture Round | - |
| 3/2019 | Chameleon Biosciences | Seed Round | 3M |
| 1/2020 | Inhalon Biopharma | Seed Round | - |
| 1/2018 | TheraDep | Venture Round | - |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 7/2007 | Verdezyne | Series C | 7M |
| 1/2015 | AskVet | Seed Round | - |
| 1/2016 | AskVet | Venture Round | - |
| 6/2019 | Embolx | Seed Round | - |
| 11/2007 | Vaxart | Series A | 0 |
| 1/2020 | S2 Genomics | Venture Round | - |
| 6/2014 | Trak | Angel Round | 1.8M |
| 4/2021 | Strategikon Pharma | Series A | - |
| 1/2018 | Seal Rock Therapeutics | Seed Round | - |
| 1/2017 | Seal Rock Therapeutics | Seed Round | - |
| 6/2013 | NuMedii | Series A | 3.5M |
| 5/2013 | Nanostim | Venture Round | 9.5M |
| 1/2017 | Embolx | Venture Round | - |
| 1/2011 | OncoHealth | Angel Round | 1.3M |
| 1/2016 | Embolx | Venture Round | - |
| 12/2020 | Strategikon Pharma | Seed Round | - |
| 5/2021 | Astrocyte Pharmaceuticals | Series A | 0 |
| 1/2015 | Retrotope | Series B | 0 |
| 1/2018 | InvVax | Venture Round | - |
| 3/2021 | VisiCELL Medical | Venture Round | - |
| 3/2022 | InnoSIGN | Series A | 8.1M |
| 6/2018 | Mission Bio | Venture Round | - |
| 6/2012 | Gemmus Pharma | Series A | 1.8M |
| 5/2019 | Chimera Bioengineering | Venture Round | 23.2M |
| 9/2021 | Avisi Technologies | Seed Round | 0 |
| 11/2007 | Allylix | Venture Round | 3.4M |
| 1/2019 | S2 Genomics | Venture Round | - |
| 8/2013 | Physcient | Series A | 1.9M |
| 1/2021 | Allyx Therapeutics | Venture Round | - |
| 9/2018 | Virion Therapeutics | Series A | 0 |
| 6/2015 | InvVax | Venture Round | - |
| 7/2022 | Avisi Technologies | Seed Round | 4.1M |
| 5/2014 | Gemmus Pharma | Series B | 3.3M |
| 1/2019 | First Light Diagnostics | Series A | 0 |
| 4/2010 | Allylix | Series C | 3M |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 3/2020 | Anubis Bio | Seed Round | 1M |
| 11/2009 | Verdezyne | Venture Round | 0 |
| 1/2010 | Vaxart | Series B | 0 |
| 8/2015 | Ask.Vet | Seed Round | 0 |
| 1/2021 | Celldom, Inc | Venture Round | - |
| 5/2011 | MoMelan Technologies | Series A | - |
| 8/2006 | Zogenix | Series A | 60M |
| 5/2011 | OncoHealth | Series A | 1.6M |
| 9/2011 | Niveus Medical | Series A | 2M |
| 10/2007 | Fluxion Biosciences | Series B | 7M |
| 8/2015 | Thrive Bioscience | Seed Round | 4M |
| 8/2013 | Carmenta Bioscience | Seed Round | 2M |
| 4/2010 | Altheos | Series A | 20M |
| 10/2017 | Mission Bio | Series A | 10M |
| 4/2013 | nVision Medical | Series A | 0 |
| 1/2021 | Saccharo | Venture Round | - |
| 1/2021 | Watershed Therapeutics | Seed Round | - |
| 3/2008 | Breathe Technologies | Series B | 15M |
| 2/2006 | Verdezyne | Series B | 1.6M |
| 11/2009 | Velomedix | Series A | 0 |
| 1/2017 | InvVax | Venture Round | - |
| 1/2020 | iDENTICAL | Seed Round | - |
| 3/2007 | VasoNova | Series A | 1.3M |
| 1/2019 | Purissima | Seed Round | - |
| 1/2019 | TeVido BioDevices | Venture Round | 1.2M |
| 12/2019 | S2 Genomics | Seed Round | - |
| 9/2019 | VALFIX Medical | Venture Round | 1.1M |
| 3/2017 | Nanotech Biomachines | Seed Round | - |
| 7/2014 | Nanotech Biomachines | Venture Round | - |
| 1/2020 | Stimwave Technologies | Venture Round | - |
| 1/2020 | BioTrace Medical | Venture Round | - |
| 9/2014 | Zephyrus Biosciences | Seed Round | 1.5M |
| 1/2020 | Eumentis Therapeutics | Seed Round | - |
| 3/2020 | Noctrix Health | Seed Round | - |
| 1/2020 | Noctrix Health | Seed Round | - |
| 1/2018 | Ark.one Health | Venture Round | - |
| 3/2008 | Satoris | Series B | 5.2M |
| 10/2005 | NSpine | Series A | 415k |
| 1/2020 | Sandstone Diagnostics | Venture Round | - |
| 3/2022 | InnoSIGN | Series A | 0 |
| 9/2021 | Avisi Technologies | Seed Round | 0 |
| 5/2021 | Astrocyte Pharmaceuticals | Series A | 0 |
| 4/2021 | Strategikon Pharma | Series A | - |
| 3/2021 | VisiCELL Medical | Venture Round | - |
| 1/2021 | Saccharo | Venture Round | - |
| 1/2021 | Watershed Therapeutics | Seed Round | - |
| 1/2021 | Celldom, Inc | Venture Round | - |
| 1/2021 | Allyx Therapeutics | Venture Round | - |
| 12/2020 | Strategikon Pharma | Seed Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
